ADVFN - Advanced Financial Network.
HOME» NYSE » B » BSX Stock Price » BSX Stock News

Boston Scientific Share News

 Boston Scientific Corp. Stock Price
BSX Stock Price
 Boston Scientific Corp. Stock Chart
BSX Stock Chart
 Boston Scientific Corp. Stock News
BSX Stock News
 Boston Scientific Corp. Company Information
BSX Company Information
 Boston Scientific Corp. Stock Trades
BSX Stock Trades

J&J Appeals Court Decision On Stent Dispute With Boston Sci

By Anjali Athavaley Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- Johnson & Johnson's (JNJ) Cordis unit last week appealed an earlier court decision that it must pay Boston Scientific more than $40 million over a patent dispute involving stents, according to court filings. A jury had awarded Boston Scientific about $20 million; last month, U.S. Distict Court Judge Sue Robinson wrote that the company should get twice as much, citing "clear and convincing evidence that Cordis's conduct is sufficiently culpable to justify enhancing damages." Boston Scientific filed a patent infringement lawsuit against Cordis with a U.S. District Court in Minnesota in 2009. The case was later transferred to Delaware. The dispute marked one in a series of battles over stent patents between the two companies. Boston Scientific declined to comment. J&J didn't immediately respond to requests for comment. J&J shares fell a fraction to $63.96 in after-hours trading; Boston Scientific is up a fraction to $5.52. Bloomberg reported the ruling earlier. -By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

Stock News for Boston Scientific (BSX)
DateTimeHeadline
12/09/201617:22:00Nevro Announces Filing of Lawsuit by Boston Scientific
12/05/201616:08:26Statement of Changes in Beneficial Ownership (4)
12/05/201616:08:26Statement of Changes in Beneficial Ownership (4)
12/02/201607:00:00Boston Scientific Announces Agreement to Acquire Neovasc Advanced...
11/28/201618:25:00Nevro Files Lawsuit for Patent Infringement Against Boston Scientific...
11/23/201608:30:00Boston Scientific To Participate In Citi 2016 Global Healthcare...
11/22/201616:17:14Current Report Filing (8-k)
11/22/201608:36:00Boston Scientific Closes EndoChoice Acquisition
11/21/201607:00:00Boston Scientific Receives 2016 Shingo Prize for Operational...
11/16/201616:30:00Boston Scientific To Participate In Piper Jaffray 2016 Healthcare...
11/16/201613:34:00Boston Scientific Announces Positive Results Of HeartLogic™ H...
11/15/201606:30:00Boston Scientific Acquires Resectr™ Tissue Resection Device f...
11/04/201606:30:00Boston Scientific Announces Extension of the Cash Tender Offer...
11/03/201616:56:21Statement of Changes in Beneficial Ownership (4)
11/03/201616:51:34Statement of Changes in Beneficial Ownership (4)
11/03/201616:14:20Quarterly Report (10-q)
11/03/201606:30:00Boston Scientific Announces Acquisition Of The LumenR™ Tissue R...
11/02/201609:43:00Boston Scientific Announces Initial U.S. Commercial Performance...
11/02/201608:45:00The Shift of Medical Devices to a Home Setting
11/01/201616:11:05Statement of Changes in Beneficial Ownership (4)

Boston Scientific and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US